Bionano Genomics, Inc. (Nasdaq: BNGO) today announced publication of a peer-reviewed study in Modern Pathology showing that optical genome mapping (OGM) detected genomic abnormalities in 97.8% of ...
On May 29, 2026, Kuva Labs, Inc. (“Kuva” or “Parent”) and Lisata Therapeutics, Inc. (“Lisata”) (Nasdaq: LSTA), together with Kuva’s wholly owned subsidiary Kuva Acquisition Corp. (“Kuva Acquisition”), ...
Dana-Farber’s Katherine Janeway, M.D., discusses how reimbursement policies for molecular diagnostics have failed to keep pace with scientific evidence, leaving gaps in the care for pediatric bone ...
A new review highlights how human evolution has shaped the presence of pathogenic variations in DNA damage repair (DDR) genes, offering a new perspective on why modern populations face increased ...
Modifiable risk factors such as alcohol consumption, BMI, dietary patterns and smoking could shift cancer risk as much as 60% ...
Researchers at University of California San Diego have developed a new artificial intelligence (AI) model that can translate ...
Grail's multi-cancer blood test can find cancer — but there's still one big problem with how it works.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results